Clinical Trial Update: Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating deferiprone alone or in combination with desferrioxamine for iron overload in transfusion-dependent patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis

Drugs mentioned

• Deferiprone (deferiprone)
• Desferrioxamine (deferoxamine)

Snippet

Sponsor: Lipomed | Conditions: Hemochromatosis | Phase 2 | Status: COMPLETED